Pages

Thursday, May 07, 2009

Drug Company Money is Top Factor in Publication of Vaccine Studies

Flu vaccine studies that are funded by industry are significantly more likely to be published in prestigious journals and to later be cited in the scientific literature than studies without such funding, according to a survey of 274 studies conducted by researchers from the Cochrane Vaccine Field in Italy, and published in the British Medical Journal.

A good methodology, in contrast, had little impact on such factors. The study also found few studies providing good evidence that the flu vaccine is actually effective.

Read more...

No comments:

Post a Comment

Thanks for your comment it is much appreciated.